Sandbox Reserved 1073
From Proteopedia
(Difference between revisions)
												
			
			| Line 5: | Line 5: | ||
| == Introduction == | == Introduction == | ||
| - | The Enoyl-ACP Reductase InhA, from ''Mycobacterium tuberculosis'', catalyzes the NADH-dependent reduction of long-chain ''trans''-2-enoyl-ACP fatty acids in the type II fatty acid biosynthesis pathway of ''M.'' ''tuberculosis''. InhA is a member of the short chain dehydrogenase/reductase (SDR) family of enzymes.  | + | The Enoyl-ACP Reductase InhA, from ''Mycobacterium tuberculosis'', catalyzes the NADH-dependent reduction of long-chain ''trans''-2-enoyl-ACP fatty acids in the type II fatty acid biosynthesis pathway of ''M.'' ''tuberculosis''. InhA is a member of the short chain dehydrogenase/reductase [http://en.wikipedia.org/wiki/Short-chain_dehydrogenase short chain dehydrogenase/reductase] (SDR) family of enzymes.  | 
| === FAS-II System === | === FAS-II System === | ||
Revision as of 12:14, 31 March 2015
| This Sandbox is Reserved from 02/09/2015, through 05/31/2016 for use in the course "CH462: Biochemistry 2" taught by Geoffrey C. Hoops at the Butler University. This reservation includes Sandbox Reserved 1051 through Sandbox Reserved 1080. | 
| To get started: 
 More help: Help:Editing | 
Enoyl-ACP Reductase InhA
| 
 | |||||||||||
